XT Venture Capital provides future category leaders with
capital, advice, and support throughout their entire journey

Years of
experience
1 +
Direct
investments
0 +
IPOs &
M&As
0 +
Unicorns
and counting
0

IPO/Acquired

IPO/Acquired

We know what it takes,
and we bring it to the table

For more than two decades, we’ve backed unique category leaders that emerged  from Israel. When partnering, we see it as our mission to make the management teams as successful as possible, supporting them with capital, a broad network of connections, operational knowhow, and 24/7 advice – all based on decades of experience in taking companies from any stage to category leadership.

The Team

Investing in category leaders

Since the late 90s, we’ve seen waves of innovations, and took an active role in some big successes as well as in painful failures. However, by carefully implementing our strategy, we managed to be a significant ingredient in the creation of market leaders like Checkmarx, Enzymotec, and Lumenis.


Our track record empowers us to invest in those companies we believe will be the next category leaders – even in categories that are still under construction.

Investing with passion

We invest only in companies where we are as excited about their mission as the management teams - and we are all super excited. We believe in true partnerships, so before joining we try to learn how we can work together all the way, through highs and lows that are always part of the journey.
We have the deepest appreciation for the sacrifices made to build a company, so we offer management teams all, and only, the support they ask for, thus making sure we do not interfere in running the business. We believe this is key for a healthy, long-term partnership.
We will extend our management teams all the help they need, and we always cherish the sacrifice required to build a company We believe all these are key for a healthy long-term partnership.

XT backed companies
in the press

H&F to acquire cybersecurity startup Checkmarx according to $1.15b

Published in CTECH

The American private equity firm is buying Checkmarx from current owner Insight Partners

JPMorgan Chase to buy Conduit stake for $100m

Published in Globes

Yozma will reportedly sell 7% of Internet company Conduit to JPMorgan Chase at a company value of $1.3b

Epitomee Medical Ltd. and Nestlé Health Science announced partnership

Partnership will enable Epitomee to reach millions of people around the world suffering from obesity

Honeywell completes acquisition
of Nextnine LTD

Addition of Nextnine further strengthens Honeywell’s leadership in industrial cyber security

Israeli company PainReform raises $23m in Nasdaq IPO

The Herzliya-based pain therapeutics company held the IPO at a company valuation of $70m

Everysight Raptor review: Cycling smartglasses that make a great riding.

The Everysight Raptor is a pair of AR smartglasses built for cyclists and triathletes that’s packed.